MDA-9/syntenin is a key regulator of glioma pathogenesis

Neuro-Oncology

Volumn 16, Issue 1, 2014, Pages 50-61

  Kegelman, Timothy P ^a   Das, Swadesh K ^a,b,c   Hu, Bin ^a   Bacolod, Manny D ^a,b,c   Fuller, Christine E ^b   Menezes, Mitchell E ^a   Emdad, Luni ^a,b,c   Dasgupta, Santanu ^a,b,c   Baldwin, Albert S ^d   Bruce, Jeffrey N ^e   Dent, Paul ^b,c   Pellecchia, Maurizio ^f   Sarkar, Devanand ^a,b,c   Fisher, Paul B ^a,b,c  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e New York Presbyterian Columbia University Medical Center   (United States)

^f BURNHAM INSTITUTE   (United States)

Author keywords

GBM; glioma; intracranial injection; invasion; MDA 9 syntenin

Indexed keywords

GELATINASE A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MATRIGEL; MITOGEN ACTIVATED PROTEIN KINASE P38; SHORT HAIRPIN RNA; SYNTENIN; PROTEIN TYROSINE KINASE; SDCBP PROTEIN, HUMAN;

ANCHORAGE INDEPENDENT GROWTH; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTOMA; CARCINOGENESIS; CELL MIGRATION; CYTOKINE RELEASE; DATA BASE; FEMALE; GAIN OF FUNCTION MUTATION; GENE EXPRESSION; GLIOMA; HUMAN; HUMAN CELL; IN VIVO STUDY; LOSS OF FUNCTION MUTATION; MOUSE; NEUROEPITHELIOMA; NONHUMAN; ONCOGENE SRC; PATHOGENESIS; PHENOTYPE; TUMOR INVASION; TUMOR MICROENVIRONMENT; TUMOR VOLUME; TUMOR XENOGRAFT; ANIMAL; APOPTOSIS; BRAIN NEOPLASMS; CANCER GRADING; CELL ADHESION; CELL MOTION; CELL PROLIFERATION; CHICKEN; CHORIOALLANTOIS; COMPARATIVE STUDY; DRUG SCREENING; ENZYME IMMUNOASSAY; GENE EXPRESSION REGULATION; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; PATHOLOGY; TUMOR CELL CULTURE; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CHICKENS; CHORIOALLANTOIC MEMBRANE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; IMMUNOENZYME TECHNIQUES; MICE; MICE, NUDE; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SRC-FAMILY KINASES; SYNTENINS; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84891510839     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/not157     Document Type: Article

References (50)

1. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2008. Hinsdale, IL: Central Brain Tumor Registry of the United States; 2012
2. Kleihues P, Louis DN, Scheithauer BW, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol. 2002;61(3): 215-225; discussion 226-219
3. Nakada M, Nakada S, Demuth T, Tran NL, Hoelzinger DB, Berens ME. Molecular targets of glioma invasion. Cell Mol Life Sci. 2007;64(4): 458-478
4. Onishi M, Ichikawa T, Kurozumi K, Date I. Angiogenesis and invasion in glioma. Brain Tumor Pathol. 2011;28(1):13-24
5. Burger PC, Heinz ER, Shibata T, Kleihues P. Topographic anatomyand CT correlations in the untreated glioblastoma multiforme. J Neurosurg. 1988;68(5):698-704
6. Westphal M, Lamszus K. The neurobiology of gliomas: Fromcell biology to the developmentof therapeuticapproaches.NatRev Neurosci. 2011; 12(9):495-508
7. Beadle C, Assanah MC, Monzo P, Vallee R, Rosenfeld SS, Canoll P. The role of myosin II in glioma invasion of the brain. Mol Biol Cell. 2008;19(8): 3357-3368
8. Lin JJ, Jiang HP, Fisher PB. Characterization of a novel melanoma differentiation-Associated gene, mda-9, that is down-regulated during terminal cell differentiation. Mol Cell Differ. 1996;4(4):317-333
9. Grootjans JJ, Zimmermann P, Reekmans G, et al. Syntenin, a PDZ protein that binds syndecan cytoplasmic domains. Proc Natl Acad Sci U S A. 1997;94(25):13683-13688
10. Sarkar D, Boukerche H, Su ZZ, Fisher PB. Mda-9/syntenin:more than just a simple adapter protein when it comes to cancer metastasis. Cancer Research. 2008;68(9):3087-3093
11. Sarkar D, Boukerche H, Su ZZ, Fisher PB. Mda-9/syntenin: Recent insights into a novel cell signaling and metastasis-Associated gene. Pharmacol Ther. 2004;104(2):101-115
12. Das SK, Bhutia SK, Kegelman TP, et al. MDA-9/syntenin: A positive gatekeeper of melanoma metastasis. Front Biosci. 2012;17:1-15
13. Beekman JM, Coffer PJ. The ins and outs of syntenin, a multifunctional intracellular adaptor protein. J Cell Sci. 2008;121(Pt 9):1349-1355
14. Lin JJ, Jiang H, Fisher PB. Melanoma differentiation associated gene-9, mda-9, is a human gamma interferon responsive gene. Gene. 1998; 207(2):105-110
15. Boukerche H, Su ZZ, Emdad L, Sarkar D, Fisher PB. Mda-9/syntenin regulates the metastatic phenotype in human melanoma cells by activating nuclear factor-kappaB. Cancer Res. 2007;67(4):1812-1822
16. Boukerche H, Su ZZ, Prevot C, Sarkar D, Fisher PB. Mda-9/syntenin promotes metastasis in human melanoma cells by activating c-Src. Proc Natl Acad Sci USA. 2008;105(41):15914-15919
17. Boukerche H, Su ZZ, Emdad L, et al. Mda-9/syntenin: A positive regulator of melanomametastasis. Cancer Res. 2005;65(23):10901-10911
18. Boukerche H, Aissaoui H, Prevost C, et al. Src kinase activation is mandatory for MDA-9/syntenin-mediated activation of nuclear factor-kappaB. Oncogene. 2010;29(21):3054-3066
19. Koo TH, Lee JJ, Kim EM, Kim KW, Kim HD, Lee JH. Syntenin is overexpressed and promotes cell migration in metastatic human breast and gastric cancer cell lines. Oncogene. 2002;21(26): 4080-4088
20. Zhong D, Ran JH, Tang WY, et al. Mda-9/syntenin promotes human brain glioma migration through focal adhesion kinase (FAK)-JNK and FAK-AKT signaling. Asian Pac J Cancer Prev. 2012;13(6):2897-2901
21. Lambaerts K, Van Dyck S, Mortier E, et al. Syntenin, a syndecan adaptor and an Arf6 phosphatidylinositol 4,5-bisphosphate effector, is essential for epiboly and gastrulation cell movements in zebrafish. J Cell Sci. 2012;125(Pt 5):1129-1140
22. Tomoda T, Kim JH, Zhan C, Hatten ME. Role of Unc51.1 and its binding partners in CNS axon outgrowth. Genes Dev. 2004;18(5):541-558
23. Dash R, Dmitriev I, Su ZZ, et al. Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) improves therapeutic efficacy in low CAR prostate cancer cells. Cancer Gene Therapy. 2010;17(7): 447-456
24. Mittereder N, March KL, Trapnell BC. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J Virol. 1996; 70(11):7498-7509
25. Yacoub A, Hamed H, Emdad L, et al. MDA-7/IL-24 plus radiation enhance survival in animals with intracranial primary human GBM tumors. Cancer Biol Ther. 2008;7(6):917-933
26. Su ZZ, Leszczyniecka M, Kang DC, et al. Insights into glutamate transport regulation in human astrocytes: Cloning of the promoter for excitatory amino acid transporter 2 (EAAT2). Proc Natl Acad Sci U S A. 2003;100(4):1955-1960
27. Emdad L, Lee SG, Su ZZ, et al. Astrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesis. Proc Natl Acad Sci U S A. 2009;106(50):21300-21305
28. Pfeifer A, Kessler T, Silletti S, Cheresh DA, Verma IM. Suppression of angiogenesis by lentiviral delivery of PEX, a noncatalytic fragment of matrix metalloproteinase 2. Proc Natl Acad Sci U S A. 2000;97(22): 12227-12232
29. SunL, Hui A-M, SuQ, et al. Neuronalandglioma-derivedstemcell factor induces angiogenesis within the brain. Cancer Cell. 2006;9(4): 287-300
30. Goldman M, Craft B, Swatloski T, et al. The UCSC Cancer Genomics Browser: Update 2013. Nucleic Acids Res. 2013;41(Database issue): D949-D954
31. Cayre M, Canoll P, Goldman JE. Cell migration in the normal and pathological postnatal mammalian brain. Prog Neurobiol. 2009; 88(1):41-63
32. Hemler ME. Integrin associated proteins. Curr Opin Cell Biol. 1998;10(5): 578-585
33. Paulus W, Baur I, Beutler AS, Reeves SA. Diffuse brain invasion of glioma cells requires beta 1 integrins. Lab Invest. 1996;75(6):819-826
34. Hwangbo C, Kim J, Lee JJ, Lee JH. Activation of the integrin effector kinase focal adhesion kinase in cancer cells is regulated by crosstalk between protein kinase Calpha and the PDZ adapter protein mda-9/ syntenin. Cancer Res. 2010;70(4):1645-1655
35. Schlaepfer DD, Mitra SK. Multiple connections link FAK to cell motility and invasion. Curr Opin Genet Dev. 2004;14(1):92-101
36. D'Abaco GM, Kaye AH. Integrin-linked kinase: A potential therapeutic target for the treatment of glioma. J Clin Neurosci. 2008;15(10): 1079-1084
37. Engelman JA, Luo J, Cantley LC. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet. 2006;7(8):606-619
38. Delcommenne M, Tan C, Gray V, Rue L, Woodgett J, Dedhar S. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Acad Sci U S A. 1998;95(19):11211-11216
39. Morimoto AM, Tomlinson MG, Nakatani K, Bolen JB, Roth RA, Herbst R. The MMAC1 tumor suppressor phosphatase inhibits phospholipase C and integrin-linked kinase activity. Oncogene. 2000;19(2):200-209
40. Watanabe A, Mabuchi T, Satoh E, et al. Expression of syndecans, a heparan sulfate proteoglycan, in malignant gliomas: Participation of nuclear factor-kappaB in upregulation of syndecan-1 expression. J Neurooncol. 2006;77(1):25-32
41. Paugh BS, Paugh SW, Bryan L, et al. EGF regulates plasminogen activator inhibitor-1 (PAI-1) by a pathway involving c-Src, PKCdelta, and sphingosine kinase 1 in glioblastoma cells. FASEB J. 2008;22(2): 455-465
42. Lu KV, Zhu S, Cvrljevic A, et al. Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients. Cancer Res. 2009;69(17):6889-6898
43. Yang M, Li Y, Chilukuri K, et al. L1 stimulation of human glioma cell motility correlates with FAK activation. J Neurooncol. 2011; 105(1):27-44
44. Feng H, Hu B, Jarzynka MJ, et al. Phosphorylation of dedicator of cytokinesis 1 (Dock180) at tyrosine residue Y722 by Src family kinases mediates EGFRvIII-driven glioblastoma tumorigenesis. Proc Natl Acad Sci U S A. 2012;109(8):3018-3023
45. Dasgupta S, Menezes M, Das SK, et al. Novel role of MDA-9/syntenin in regulating urothelial cell proliferation by modulating EGFR signaling. Clin Cancer Res. 2013;19(17):4621-4633
46. Hu YL, DeLay M, Jahangiri A, et al. Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma. Cancer Res. 2012;72(7):1773-1783
47. Bonavia R, Inda MM, Vandenberg S, et al. EGFRvIII promotes glioma angiogenesis and growth through the NF-kappaB, interleukin-8 pathway. Oncogene. 2012;31(36):4054-4066
48. Raychaudhuri B, Vogelbaum MA. IL-8 is a mediator of NF-kappaB induced invasion by gliomas. J Neurooncol. 2011;101(2):227-235
49. Baietti MF, Zhang Z, Mortier E, et al. Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol. 2012;14(7):677-685
50. National Cancer Institute. 2005. REMBRANDT home page. http:// rembrandt.nci.nih.gov. Accessed 2012